49 | VaccinesIBA
05/2024
-
01/2004 |
49 | AntibodiesIBA
04/2024
-
06/2003 |
44 | AntigensIBA
05/2024
-
02/2006 |
43 | Immunoglobulin G (IgG)IBA
05/2024
-
01/2004 |
31 | Proteins (Proteins, Gene)FDA Link
01/2022
-
05/2002 |
22 | Malaria VaccinesIBA
01/2022
-
12/2005 |
14 | Glutamic Acid (Glutamate)FDA Link
08/2020
-
01/2004 |
10 | Membrane Proteins (Integral Membrane Proteins)IBA
08/2020
-
01/2004 |
7 | Merozoite Surface Protein 1 (MSA1)IBA
05/2024
-
01/2004 |
6 | Antimalarials (Antimalarial Agents)IBA
01/2023
-
07/2012 |
5 | Immunoglobulin M (IgM)IBA
05/2024
-
02/2008 |
5 | Aluminum Hydroxide (Algeldrate)FDA Link
01/2024
-
01/2016 |
5 | Rabies Vaccines (Rabies Vaccine)FDA Link
01/2021
-
01/2011 |
4 | Surface Antigens (Surface Antigen)IBA
11/2022
-
01/2004 |
4 | 1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
06/2022
-
01/2019 |
4 | EpitopesIBA
01/2022
-
12/2016 |
4 | Recombinant ProteinsIBA
01/2021
-
02/2006 |
4 | EnzymesIBA
01/2020
-
06/2003 |
4 | ImmunosorbentsIBA
01/2020
-
06/2003 |
4 | Peptides (Polypeptides)IBA
02/2016
-
05/2002 |
3 | Immunoglobulins (Immunoglobulin)IBA
01/2022
-
08/2020 |
3 | aluminum sulfate (alum)IBA
01/2021
-
02/2005 |
3 | Subunit VaccinesIBA
04/2016
-
12/2005 |
3 | 5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA
04/2015
-
09/2004 |
2 | B-Lymphocyte Epitopes (B-Cell Epitope)IBA
02/2023
-
12/2005 |
2 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
-
01/2014 |
2 | IgG Receptors (Fc gamma RI)IBA
11/2022
-
01/2014 |
2 | artemisinin (artemisinine)IBA
01/2022
-
01/2021 |
2 | LigandsIBA
01/2018
-
06/2003 |
2 | Complement System Proteins (Complement)IBA
02/2016
-
11/2009 |
2 | Biomarkers (Surrogate Marker)IBA
01/2012
-
11/2007 |
1 | SaponinsIBA
02/2024 |
1 | Matrix-MIBA
01/2024 |
1 | GMZ2 vaccineIBA
01/2022 |
1 | insulin receptor-related receptor (IRR)IBA
01/2022 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2022 |
1 | Albendazole (Albenza)FDA Link
04/2021 |
1 | AnthelminticsIBA
04/2021 |
1 | Blood Group Antigens (Blood Groups)IBA
08/2020 |
1 | Staphylococcal Protein A (Protein A)IBA
01/2020 |
1 | Cysteine (L-Cysteine)FDA Link
01/2020 |
1 | EmulsionsIBA
01/2019 |
1 | Protein Subunit VaccinesIBA
01/2019 |
1 | LipidsIBA
01/2019 |
1 | Recombinant DNA (Recombinant DNA Research)IBA
01/2019 |
1 | T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2018 |
1 | 1-oleoyl-2-stearoylphosphatidylcholineIBA
12/2016 |
1 | OspC proteinIBA
12/2016 |
1 | pyrimethamine drug combination fanasil (Fansidar)FDA Link
10/2015 |
1 | Amodiaquine (Camoquin)FDA Link
10/2015 |
1 | Fc gamma receptor IIAIBA
02/2015 |
1 | Indicators and Reagents (Reagents)IBA
08/2013 |
1 | Broadly Neutralizing AntibodiesIBA
02/2013 |
1 | Coloring Agents (Dyes)IBA
07/2012 |
1 | red dye CMXRosIBA
07/2012 |
1 | Pyrimethamine (Daraprim)FDA Link
01/2012 |
1 | VirosomesIBA
12/2011 |
1 | DefensinsIBA
02/2011 |
1 | Eosinophil Cationic ProteinIBA
01/2011 |
1 | Immunoglobulin IsotypesIBA
01/2009 |
1 | Liposomes (Liposome)IBA
09/2008 |
1 | Oligonucleotide ProbesIBA
11/2007 |
1 | beta-Globins (beta Globin)IBA
02/2006 |
1 | Hemoglobins (Hemoglobin)IBA
02/2006 |
1 | Sickle HemoglobinIBA
02/2006 |
1 | Monatide (IMS 3015)IBA
02/2005 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2005 |
1 | Complement Factor H (Factor H)IBA
06/2003 |